Literature DB >> 11250946

Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat.

P S Brereton1, R R van Driel, K Koyama, R Dilley, Z Krozowski.   

Abstract

The 11beta-hydroxysteroid dehydrogenase type I enzyme (11betaHSD1) converts cortisone to cortisol in humans, and 11-dehydrocorticosterone to corticosterone in rodents. In the present study we used a new immunopurified polyclonal antibody, RAH113, to localize 11betaHSD1 at the light and electron microscopy levels in a wide range of rat tissues. 11betaHSD1 staining in the liver was of highest intensity around the central vein and decreased radially. In the lung, 11betaHSD1 was found at highest levels in the interstitial fibroblast, with levels in the type II pneumocyte an order of magnitude lower. RAH113 stained proximal tubules of the renal cortex and interstitial cells of the medulla and papilla. Adrenal 11betaHSD1 was confined to the glomerulosa and medulla, whereas the glucocorticoid-inactivating hydroxysteroid dehydrogenase isoform 11betaHSD2 was present in fascilulata/reticularis. 11betaHSD1 was found in parietal cells of the fundic region of the stomach, but not in the antrum. In the heart, 11betaHSD1 was detected in cells resembling interstitial fibroblasts of the endocardium and in the adventitial fibroblasts of blood vessels. Western blot analysis confirmed the presence of an antigen of the correct size (34 kDa) and intensity consistent with levels of enzyme activity previously reported in these tissues. Brain and testis also displayed the 34-kDa protein, confirming the expression of authentic 11betaHSD1 in these tissues. Electron microscopy of lung and kidney interstitial cells showed that 11betaHSD1 was localized both to the endoplasmic reticulum and the nuclear membrane. These results show that 11betaHSD1 is present in discrete cell populations where it may facilitate intracrine and paracrine glucocorticoid action in addition to its classical role of maintaining circulating glucocorticoids via activity in the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250946     DOI: 10.1210/endo.142.4.8088

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Immunolocalisation of 11β-HSD-1 and -2, glucocorticoid receptor, mineralocorticoid receptor and Na+ K+-ATPase during the postnatal development of the rat epididymis.

Authors:  Gwyneth H Gladstones; Peter J Burton; Peter J Mark; Brendan J Waddell; Peter Roberts
Journal:  J Anat       Date:  2012-04       Impact factor: 2.610

2.  Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.

Authors:  Dale S Edgerton; Rita Basu; Christopher J Ramnanan; Tiffany D Farmer; Doss Neal; Melanie Scott; Peer Jacobson; Robert A Rizza; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-16       Impact factor: 4.310

3.  Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.

Authors:  Elise P Gomez-Sanchez; Damian G Romero; Angela F de Rodriguez; Mary P Warden; Zygmunt Krozowski; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

4.  DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins.

Authors:  Zoltan Balazs; Roberto A S Schweizer; Felix J Frey; Françoise Rohner-Jeanrenaud; Alex Odermatt
Journal:  J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 10.121

5.  11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.

Authors:  A Swali; E A Walker; G G Lavery; J W Tomlinson; P M Stewart
Journal:  Diabetologia       Date:  2008-09-09       Impact factor: 10.122

6.  Immunohistochemical demonstration of the mineralocorticoid receptor, 11beta-hydroxysteroid dehydrogenase-1 and -2, and hexose-6-phosphate dehydrogenase in rat ovary.

Authors:  Elise P Gomez-Sanchez; Miriam T Gomez-Sanchez; Angela F de Rodriguez; Damian G Romero; Mary P Warden; Maria W Plonczynski; Celso E Gomez-Sanchez
Journal:  J Histochem Cytochem       Date:  2009-03-02       Impact factor: 2.479

Review 7.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 8.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

9.  Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Gareth G Lavery; Agnieszka E Zielinska; Laura L Gathercole; Beverly Hughes; Nina Semjonous; Phillip Guest; Khalid Saqib; Mark Sherlock; Gary Reynolds; Stuart A Morgan; Jeremy W Tomlinson; Elizabeth A Walker; Elizabeth H Rabbitt; Paul M Stewart
Journal:  Endocrinology       Date:  2012-05-03       Impact factor: 4.736

10.  Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation.

Authors:  Rowan S Hardy; Andrew Filer; Mark S Cooper; Greg Parsonage; Karim Raza; Debbie L Hardie; Elizabeth H Rabbitt; Paul M Stewart; Christopher D Buckley; Martin Hewison
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.